1. 1) Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. The Metabolic and Molecular Bases of Inherited Disease, 8th Ed. (Scriver CR, Beaudet AL, Valle D, Sly WS eds.) McGraw-Hill, New York, pp. 2007–2056 (2001).
2. 2) Azzini E, Ruggeri S, Polito A. Homocysteine: Its possible emerging role in at-risk population groups. Int. J. Mol. Sci., 21, 1421 (2020).
3. 3) Moretti R, Caruso P. The controversial role of homocysteine in neurology: From labs to clinical practice. Int. J. Mol. Sci., 20, 231 (2019).
4. 4) Zhou F, Chen S. Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies. Ageing Res. Rev., 51, 55–66 (2019).
5. 5) Imbard A, Benoist JF, Blom HJ. Neural tube defects, folic acid and methylation. Int. J. Environ. Res. Public Health, 10, 4352–4389 (2013).